0000950170-24-080600.txt : 20240702 0000950170-24-080600.hdr.sgml : 20240702 20240702164427 ACCESSION NUMBER: 0000950170-24-080600 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240628 FILED AS OF DATE: 20240702 DATE AS OF CHANGE: 20240702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Balcom Alexandra CENTRAL INDEX KEY: 0001862147 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 241096345 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 ownership.xml 4 X0508 4 2024-06-28 0001861560 Nuvalent, Inc. NUVL 0001862147 Balcom Alexandra C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 false true false false Chief Financial Officer true Class A Common Stock 2024-06-28 4 M false 10000 27.85 A 43300 D Class A Common Stock 2024-06-28 4 S false 7565 75.15 D 35735 D Class A Common Stock 2024-06-28 4 S false 1863 76.19 D 33872 D Class A Common Stock 2024-06-28 4 S false 572 76.73 D 33300 D Stock Option (Right to Buy) 27.85 2024-06-28 4 M false 10000 0 D 2033-01-06 Class A Common Stock 10000 134200 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.56 to $75.54, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.56 to $76.55, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.56 to $77.18, inclusive. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. /s/ Nathan McConarty, attorney-in-fact 2024-07-02